Kain Science passes technical evaluation for KOSDAQ special listing Kain Science moves closer to KOSDAQ listing after ...

Analysts have recently evaluated KORU Medical Systems and provided 12-month price targets. The average target is $4.7, ...

Analysts at B. Riley boosted their FY2024 EPS estimates for shares of KORU Medical Systems in a research report issued on ...

Dianthus Therapeutics is advancing treatments for autoimmune diseases. Read why DNTH stock is receiving Buy ratings and price ...

KORU Medical Systems, Inc. recently disclosed its financial standing for the fiscal quarter and year closing on December 31, ...

Illinois regulators have added endometriosis, ovarian cysts, uterine fibroids and female orgasmic disorder to the conditions ...

JMP Securities analyst Jason Butler raised the firm’s price target on Argenx (ARGX) to $696 from $606 and keeps an Outperform rating on the ...

Reported $2.2 billion in preliminary* full-year 2024 global product net sales, inclusive of $737 million in fourth quarter sales Pre-filled syringe FDA PDUFA on track for April 2025 to support reachin ...

and chronic inflammatory demyelinating polyneuropathy (CIDP) in the U.S., Japan, and China. Regulatory decisions on approval of VYVGART for gMG expected in first half of 2025, including in Israel (SC) ...

JNJ's filing seeks the FDA's approval for nipocalimab to treat generalized myasthenia gravis in a broad population of ...

SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with ...

Soleo Health, a leader and national provider of complex specialty pharmacy services, announced Jan. 7 the opening of its new ...